Tudor Investment Corp’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-165
Closed -$51K 1405
2020
Q3
$51K Sell
165
-272
-62% -$84.1K ﹤0.01% 1199
2020
Q2
$164K Sell
437
-90
-17% -$33.8K 0.01% 1040
2020
Q1
$120K Buy
527
+110
+26% +$25K 0.01% 903
2019
Q4
$220K Buy
417
+82
+24% +$43.3K 0.01% 955
2019
Q3
$144K Buy
+335
New +$144K ﹤0.01% 969
2016
Q3
Sell
-550
Closed -$400K 1474
2016
Q2
$400K Buy
+550
New +$400K 0.01% 840